Skip to main content
  • Home
  • Courses/Webinars
    Adrenal Bone Diabetes/Metabolism/Obesity Mentorship Hypothalamus-Pituitary Reproductive Thyroid
  • Microlearning
    MEDBuzz (YouTube Channel) Ask the Expert
  • Resources
  • Meetings
    ISE Meetings Partner Events
  • Supporters
  • You are not logged in. (Log in)
Skip Searchresources
Searchresources
    Sort by:
    • alphabetisch
    • alphabetisch
    • date
    • date
    Add event filter
      Loading
      1. Home
      2. Overview
      3. Courses/Webinars
      4. Hypothalamus-Pituitary
      Prader-Willi Syndrome (PWS) through the eyes of a physician, an allied health professional, and a caregiver

      This is a CME-CPD accredited activity.
      Number of credits: 2

      Description:
      Learn more about PWS diagnosis and features in neonates, children, adolescents and adults; the importance of ongoing care; and the key aspects of daily life and support for people living with PWS and their families.
      Enter
      Acromegaly Through the Eyes of a Physician, a Nurse, and a Patient | Detection, Diagnosis, Treatment, and Follow-up Care

      This is a CME-CPD accredited activity.
      Number of credits: 1

      Description:
      Explore the challenges faced by physicians, nurses, and patients in terms of detection, diagnosis, treatment, and follow-up care in acromegaly.
      Enter
      Spotlight on Safety: How can long-term GH therapy risks be mitigated?
      This is a CME-CPD accredited activity.
      Number of credits: 1

      Description:
      Are you familiar with the known and unknown safety risks in long-term GH therapy? During this session, Peter Clayton (UK) and Charlotte Höybye (Sweden) discuss how to improve long-term safety of pediatric and adult GH replacement.
      Enter
      Transitioning hypopituitary patients from childhood to adulthood: what do endocrinologists need to know?

      This is a CME-CPD accredited activity.
      Number of credits: 1

      Description:
      During the session, the experts discuss the diagnostic challenges including the need for endocrine retesting, define criteria for continued care vs. discontinuation, and review the therapeutic shifts during the transition phase.

      Enter
      GHD Diagnosis and Management in Adults: Who to test and how to treat?

      This is a CME-CPD accredited activity.
      Number of credits: 1

      Description:
      This session will provide an overview of the diagnosis and therapy of patients with GHD in adulthood focusing on diagnostic tests, hormone interactions, and the monitoring of efficacy and safety.

      Enter
      Diabetes Insipidus - From Differential Diagnosis to Post-operative DI

      This is a CME-CPD accredited activity.
      Number of credits: 1

      Description:

      This session will help you recognize the different etiologies of the polyuria polydipsia syndrome, identify the limitations of the water deprivation test, interpret copeptin upon hypertonic saline infusion, understand non-osmotic stimuli of copeptin and their possible value in the differential diagnosis of Diabetes insipidus, have a better understanding of the pathophysiology of post-operative and post-traumatic diabetes insipidus, including the triphasic response and adipsic diabetes insipidus, and recognize patients at higher risk of post-operative DI, among other topics. 

      Enter
      What is the place of long-acting GH in the management of pediatric and adult patients?

      This is a CME-CPD accredited activity.
      Number of credits: 1

      Description:
      Join this session to become familiar with the rapidly changing field of GH treatment, particularly with regard to the move to promoting patient adherence and improving quality of life through the use of long-acting GH molecules.

      Enter
      Adult GHD: An interactive debate about diagnosis, dosage, and treatment
      This is a CME-CPD accredited activity.
      Number of credits: 2

      Description:
      During this interactive debate organized in partnership with the World Alliance of Pituitary Organizations (WAPO), the experts talk about the common symptoms of Adult GHD, the lack of consensus on the preferred diagnostic model, the common controversies around starting dosages, novel pharmacological therapies, the benefits and risks of continuing therapy, and important psychological and social well-being factors faced by adult GHD patients.

      Developed in collaboration with Dr Jens Otto Jorgensen (Denmark) and Dr Gudmundur Johannsson (Sweden).

      Enter
      Copyright © ISE. All rights reserved
      Please contact education@isendo.org with your questions.
      • Home
      • Courses/Webinars
        • Adrenal
        • Bone
        • Diabetes/Metabolism/Obesity
        • Mentorship
        • Hypothalamus-Pituitary
        • Reproductive
        • Thyroid
      • Microlearning
        • MEDBuzz (YouTube Channel)
        • Ask the Expert
      • Resources
      • Meetings
        • ISE Meetings
        • Partner Events
      • Supporters
      Get the mobile app
      Policies
      Visit our ISE Website
      You are not logged in. (Log in)